OBJECTIVE: The purpose of this study was to evaluate trends and prevalence of chronic prescription narcotic use during pregnancy and the subsequent neonatal outcomes. STUDY DESIGN: We conducted a retrospective cohort study of all deliveries at Mayo Clinic from 1998 through 2009; the data was obtained from prospectively maintained obstetrics and neonatal databases. RESULTS: Over the study time period, there were 26,314 deliveries; 167 women used prescription narcotics chronically during pregnancy. The prevalence of women who used chronic narcotics during their pregnancy increased over the time period from 1998-2009 (P < .0001). Neonatal withdrawal syndrome occurred in 10 of neonates (5.6%), and all but 1 of these neonates required pharmacologic treatment for the disease. CONCLUSION: Chronic narcotic use during pregnancy is increasing in prevalence. Neonatal withdrawal syndrome occurred in 5.6% of the exposed neonates. Although neonatal withdrawal syndrome is uncommon, it is clinically significant. Physicians need to consider the risks and benefits carefully when prescribing narcotic pain medications during pregnancy.
OBJECTIVE: The purpose of this study was to evaluate trends and prevalence of chronic prescription narcotic use during pregnancy and the subsequent neonatal outcomes. STUDY DESIGN: We conducted a retrospective cohort study of all deliveries at Mayo Clinic from 1998 through 2009; the data was obtained from prospectively maintained obstetrics and neonatal databases. RESULTS: Over the study time period, there were 26,314 deliveries; 167 women used prescription narcotics chronically during pregnancy. The prevalence of women who used chronic narcotics during their pregnancy increased over the time period from 1998-2009 (P < .0001). Neonatal withdrawal syndrome occurred in 10 of neonates (5.6%), and all but 1 of these neonates required pharmacologic treatment for the disease. CONCLUSION: Chronic narcotic use during pregnancy is increasing in prevalence. Neonatal withdrawal syndrome occurred in 5.6% of the exposed neonates. Although neonatal withdrawal syndrome is uncommon, it is clinically significant. Physicians need to consider the risks and benefits carefully when prescribing narcotic pain medications during pregnancy.
Authors: Andreea A Creanga; Cynthia J Berg; Jean Y Ko; Sherry L Farr; Van T Tong; F Carol Bruce; William M Callaghan Journal: J Womens Health (Larchmt) Date: 2014-01 Impact factor: 2.681
Authors: Suzanne D Turner; Tara Gomes; Ximena Camacho; Zhan Yao; Astrid Guttmann; Muhammad M Mamdani; David N Juurlink; Irfan A Dhalla Journal: CMAJ Open Date: 2015-01-13
Authors: Stephen W Patrick; Robert E Schumacher; Jeffrey D Horbar; Madge E Buus-Frank; Erika M Edwards; Kate A Morrow; Karla R Ferrelli; Alan P Picarillo; Munish Gupta; Roger F Soll Journal: Pediatrics Date: 2016-04-15 Impact factor: 7.124
Authors: Sudipta Sen; Sailesh Arulkumar; Elyse M Cornett; Julie A Gayle; Ronda R Flower; Charles J Fox; Alan D Kaye Journal: Curr Pain Headache Rep Date: 2016-03
Authors: Kimberly A Hekman; Violanda I Grigorescu; Lorraine L Cameron; Corinne E Miller; Ruben A Smith Journal: Am J Prev Med Date: 2013-07 Impact factor: 5.043
Authors: Amanda F Lowell; Angela N Maupin; Nicole Landi; Marc N Potenza; Linda C Mayes; Helena J V Rutherford Journal: Infant Ment Health J Date: 2020-02-14